Abstract
The multifactorial disease, cancer, frequently emerges due to perturbations in tumor suppressor genes (TSGs). However, a growing number of noncanonical target genes of TSGs and the highly interconnected nature of the human interactome reveal that the functions of TSGs are not limited to cancer-specific events. The various functions of TSGs lead to the assumption that cancer is linked with other human disorders. Therefore, a disease–gene association network of TSGs (TSDN) was constructed by integrating protein–protein interaction networks of TSGs (TSN) with Morbid Map in Online Mendelian Inheritance in Man. The TSDN revealed links between TSGs and 22 different human disorders including cancer and indicated disease–disease associations. In addition, high-density functional protein clusters in the TSN showed cohesive and overlapping disease–TSG associations, which proved the prevalent role of TSGs in various human diseases beyond cancer. The presence of overlapping disease–gene modules and disease–disease associations via the TSN demonstrated that other diseases can serve as possible roots of the life-threatening disease cancer. Therefore, a disease association map of TSGs could be a promising tool for exploring intricate relationships between cancer and other diseases for the early prediction of cancer and the understanding of disease etiology.
Similar content being viewed by others
Data availability
Datasets used in this article are available in supplementary information.
References
Amberger J, Bocchini C, Hamosh A (2011) A new face and new challenges for Online Mendelian inheritance in man (OMIM(R)). Hum Mutat 32:564–567
Aylon Y, Oren M (2011) New plays in the p53 theater. Curr Opin Genet Dev 21:86–92
Bader GD, Hogue CW (2003) An automated method for finding molecular complexes in large protein interaction networks. BMC Bioinf 4:2
Bader GD, Betel D, Hogue CW (2003) BIND: the biomolecular interaction network database. Nucleic Acids Res 31:248–250
Bandyopadhyay S, Ray S, Mukhopadhyay A, Maulik U (2015) A review of in silico approaches for analysis and prediction of HIV-1-human protein-protein interactions. Brief Bioinform 16:830–851
Barabasi AL (2016) The scale-free property. Network Science (Cambridge University Press), pp 113–163
Barabasi AL, Albert R (1999) Emergence of scaling in random networks. Science 286:509–512
Barabasi AL, Gulbahce N, Loscalzo J (2011) Network medicine: a network-based approach to human disease. Nat Rev Genet 12:56–68
Barrett T, Troup DB, Wilhite SE, Ledoux P, Rudnev D, Evangelista C, Kim IF, Soboleva A, Tomashevsky M, Marshall KA, Phillippy KH, Sherman PM, Muertter RN, Edgar R (2009) NCBI GEO: archive for high-throughput functional genomic data. Nucleic Acids Res 37:D885–D890
Bastian M, Heymann S, Jacomy M (2009) Gephi: An open source software for exploring and manipulating networks. In: International AAAI conference on weblogs and social media: ICWSM, San Jose, California
Chen L, Guo D (2017) The functions of tumor suppressor PTEN in innate and adaptive immunity. Cell Mol Immunol 14:581–589
Csardi G, Nepusz T (2006) The igraph software package for complex network research. Int J Complex Syst 1695:1–9
Duex JE, Swain KE, Dancik GM, Paucek RD, Owens C, Churchill MEA, Theodorescu D (2018) Functional impact of chromatin remodeling gene mutations and predictive signature for therapeutic response in bladder cancer. Mol Cancer Res 16:69–77
Erdős P, Rényi A (1959) On random graphs. Publ Math 6:290–297
Feldman I, Rzhetsky A, Vitkup D (2008) Network properties of genes harboring inherited disease mutations. Proc Natl Acad Sci USA 105:4323–4328
Fleming NI, Jorissen RN, Mouradov D, Christie M, Sakthianandeswaren A, Palmieri M, Day F, Li S, Tsui C, Lipton L, Desai J, Jones IT, McLaughlin S, Ward RL, Hawkins NJ, Ruszkiewicz AR, Moore J, Zhu HJ, Mariadason JM, Burgess AW, Busam D, Zhao Q, Strausberg RL, Gibbs P, Sieber OM (2013) SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer. Cancer Res 73:725–735
Forbes SA, Beare D, Boutselakis H, Bamford S, Bindal N, Tate J, Cole CG, Ward S, Dawson E, Ponting L, Stefancsik R, Harsha B, Kok CY, Jia M, Jubb H, Sondka Z, Thompson S, De T, Campbell PJ (2017) COSMIC: somatic cancer genetics at high-resolution. Nucleic Acids Res 45:D777–D783
Goh KI, Cusick ME, Valle D, Childs B, Vidal M, Barabasi AL (2007) The human disease network. Proc Natl Acad Sci USA 104:8685–8690
Hamosh A, Scott AF, Amberger J, Bocchini C, Valle D, McKusick VA (2002) Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Res 30:52–55
Ideker T, Sharan R (2008) Protein networks in disease. Genome Res 18:644–652
Jalili M, Salehzadeh-Yazdi A, Gupta S, Wolkenhauer O, Yaghmaie M, Resendis-Antonio O, Alimoghaddam K (2016) Evolution of centrality measurements for the detection of essential proteins in biological networks. Front Physiol 7:375
Jonsson PF, Bates PA (2006) Global topological features of cancer proteins in the human interactome. Bioinformatics 22:2291–2297
Knudsen ES, Wang JY (2010) Targeting the RB-pathway in cancer therapy. Clin Cancer Res 16:1094–1099
Liu W, Wu A, Pellegrini M, Wang X (2015) Integrative analysis of human protein, function and disease networks. Sci Rep 5:14344
Liyasova MS, Ma K, Lipkowitz S (2015) Molecular pathways: cbl proteins in tumorigenesis and antitumor immunity-opportunities for cancer treatment. Clin Cancer Res 21:1789–1794
Menche J, Sharma A, Kitsak M, Ghiassian SD, Vidal M, Loscalzo J, Barabasi AL (2015) Disease networks. Uncovering disease-disease relationships through the incomplete interactome. Science 347:1257601
Mersch J, Jackson MA, Park M, Nebgen D, Peterson SK, Singletary C, Arun BK, Litton JK (2015) Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian. Cancer 121:269–275
Milo R, Shen-Orr S, Itzkovitz S, Kashtan N, Chklovskii D, Alon U (2002) Network motifs: simple building blocks of complex networks. Science 298:824–827
Mora A, Donaldson IM (2011) iRefR: an R package to manipulate the iRefIndex consolidated protein interaction database. BMC Bioinf 12:455
Muller PA, Vousden KH (2013) p53 mutations in cancer. Nat Cell Biol 15:2–8
Nicolas M, Wolfer A, Raj K, Kummer JA, Mill P, van Noort M, Hui CC, Clevers H, Dotto GP, Radtke F (2003) Notch1 functions as a tumor suppressor in mouse skin. Nat Genet 33:416–421
Padala RR, Karnawat R, Viswanathan SB, Thakkar AV, Das AB (2017) Cancerous perturbations within the ERK, PI3 K/Akt, and Wnt/beta-catenin signaling network constitutively activate inter-pathway positive feedback loops. Mol BioSyst 13:830–840
Peri S, Navarro JD, Kristiansen TZ, Amanchy R, Surendranath V, Muthusamy B, Gandhi TK, Chandrika KN, Deshpande N, Suresh S, Rashmi BP, Shanker K, Padma N, Niranjan V, Harsha HC, Talreja N, Vrushabendra BM, Ramya MA, Yatish AJ, Joy M, Shivashankar HN, Kavitha MP, Menezes M, Choudhury DR, Ghosh N, Saravana R, Chandran S, Mohan S, Jonnalagadda CK, Prasad CK, Kumar-Sinha C, Deshpande KS, Pandey A (2004) Human protein reference database as a discovery resource for proteomics. Nucleic Acids Res 32:D497–D501
Pierson E, Koller D, Battle A, Mostafavi S, Ardlie KG, Getz G, Wright FA, Kellis M, Volpi S, Dermitzakis ET (2015) Sharing and specificity of co-expression networks across 35 human tissues. PLoS Comput Biol 11:e1004220
Raman K, Damaraju N, Joshi GK (2014) The organisational structure of protein networks: revisiting the centrality-lethality hypothesis. Syst Synth Biol 8:73–81
Razick S, Magklaras G, Donaldson IM (2008) iRefIndex: a consolidated protein interaction database with provenance. BMC Bioinf 9:405
Robinson DR, Wu YM, Vats P, Su F, Lonigro RJ, Cao X, Kalyana-Sundaram S, Wang R, Ning Y, Hodges L, Gursky A, Siddiqui J, Tomlins SA, Roychowdhury S, Pienta KJ, Kim SY, Roberts JS, Rae JM, Van Poznak CH, Hayes DF, Chugh R, Kunju LP, Talpaz M, Schott AF, Chinnaiyan AM (2013) Activating ESR1 mutations in hormone-resistant metastatic breast cancer. Nat Genet 45:1446–1451
Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T (2003) Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res 13:2498–2504
Stark C, Breitkreutz BJ, Reguly T, Boucher L, Breitkreutz A, Tyers M (2006) BioGRID: a general repository for interaction datasets. Nucleic Acids Res 34:D535–D539
Tan MH, Mester JL, Ngeow J, Rybicki LA, Orloff MS, Eng C (2012) Lifetime cancer risks in individuals with germline PTEN mutations. Clin Cancer Res 18:400–407
Wachi S, Yoneda K, Wu R (2005) Interactome-transcriptome analysis reveals the high centrality of genes differentially expressed in lung cancer tissues. Bioinformatics 21:4205–4208
Wang JZ, Du Z, Payattakool R, Yu PS, Chen CF (2007) A new method to measure the semantic similarity of GO terms. Bioinformatics 23:1274–1281
Wang M, Yang C, Zhang X, Li X (2018) Characterizing genomic differences of human cancer stratified by the TP53 mutation status. Mol Genet Genomics 293:737–746
Ward CL, Boggio KJ, Johnson BN, Boyd JB, Douthwright S, Shaffer SA, Landers JE, Glicksman MA, Bosco DA (2014) A loss of FUS/TLS function leads to impaired cellular proliferation. Cell Death Dis 5:e1572
Warde-Farley D, Donaldson SL, Comes O, Zuberi K, Badrawi R, Chao P, Franz M, Grouios C, Kazi F, Lopes CT, Maitland A, Mostafavi S, Montojo J, Shao Q, Wright G, Bader GD, Morris Q (2010) The GeneMANIA prediction server: biological network integration for gene prioritization and predicting gene function. Nucleic Acids Res 38:W214–W220
Xenarios I, Rice DW, Salwinski L, Baron MK, Marcotte EM, Eisenberg D (2000) DIP: the database of interacting proteins. Nucleic Acids Res 28:289–291
Xu J, Li Y (2006) Discovering disease-genes by topological features in human protein-protein interaction network. Bioinformatics 22:2800–2805
Yu G, Li F, Qin Y, Bo X, Wu Y, Wang S (2010) GOSemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics 26:976–978
Zanzoni A, Montecchi-Palazzi L, Quondam M, Ausiello G, Helmer-Citterich M, Cesareni G (2002) MINT: a molecular INTeraction database. FEBS Lett 513:135–140
Zhang Y, Fan H, Xu J, Xiao Y, Xu Y, Li Y, Li X (2013) Network analysis reveals functional cross-links between disease and inflammation genes. Sci Rep 3:3426
Zhou X, Menche J, Barabasi AL, Sharma A (2014) Human symptoms-disease network. Nat Commun 5:4212
Acknowledgements
I thank Mr.Kuntal Bhusan (Bio-Sciences R&D Division, TCS, Pune, India) for discussion regarding the statistical analysis of networks, Shiv Prasad (Software developer, Param.ai, Hyderabad, India) for assistance in writing the code in R, and Dr Urmila Saxena (NIT Warangal) for the critically reading of the manuscript and her constructive suggestion. I also thank the National Institute of Technology, Warangal for providing computational facilities.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares he has no competing interests.
Ethical approval
This article does not contain any studies with human participants or animals performed by the author.
Additional information
Communicated by S. Hohmann.
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic supplementary material
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Das, A.B. Disease association of human tumor suppressor genes. Mol Genet Genomics 294, 931–940 (2019). https://doi.org/10.1007/s00438-019-01557-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00438-019-01557-9